Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells
Andrejeva, Gabriela, Capoccia, Benjamin J, Hiebsch, Ronald R, Donio, Michael J, Darwech, Isra M, Puro, Robyn J, Pereira, Daniel S
Published in The Journal of immunology (1950) (15.02.2021)
Published in The Journal of immunology (1950) (15.02.2021)
Get full text
Journal Article
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
Puro, Robyn J, Bouchlaka, Myriam N, Hiebsch, Ronald R, Capoccia, Benjamin J, Donio, Michael J, Manning, Pamela T, Frazier, William A, Karr, Robert W, Pereira, Daniel S
Published in Molecular cancer therapeutics (01.03.2020)
Published in Molecular cancer therapeutics (01.03.2020)
Get full text
Journal Article
260 CD47 antibody, AO-176 demonstrates potent anti-tumor activity in pre-clinical solid tumor xenografts as a single agent and in combination with multiple classes of therapeutics
Andrejeva, Gabriela, Capoccia, Benjamin, Delston, Rachel, Donio, Michael, Hiebsch, Ronald, Puro, Robyn, Wilson, Casey, Kashyap, Arun, Pereira, Daniel
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Activation and Inhibition of Cellular Calcium and Tyrosine Kinase Signaling Pathways Identify Targets of the HBx Protein Involved in Hepatitis B Virus Replication
Bouchard, Michael J, Puro, Robyn J, Wang, Lihua, Schneider, Robert J
Published in Journal of Virology (01.07.2003)
Published in Journal of Virology (01.07.2003)
Get full text
Journal Article
215 AO-176, a highly differentiated clinical stage anti-CD47 antibody, preferentially binds tumor versus normal cell CD47 when complexed to β1 integrin
Puro, Robyn, Chakraborty, Prabir, Richards, John, Hiebsch, Ronald, Donio, Michael, Casey Wilson, W, Capoccia, Benjamin, Brachmann, Carrie, Sung, Vicki, Kashyap, Arun, Pereira, Daniel
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model
Sihag, Smita, Haas, Michael S, Kim, Karen M, Guerrero, J Luis, Beaudoin, Jonathan, Alicot, Elisabeth M, Schuerpf, Franziska, Gottschall, James D, Puro, Robyn J, Madsen, Joren C, Sachs, David H, Newman, Walter, Carroll, Michael C, Allan, James S
Published in Circulation. Cardiovascular interventions (01.01.2016)
Published in Circulation. Cardiovascular interventions (01.01.2016)
Get full text
Journal Article
AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms
Wilson, William Casey, Richards, John O, Andrejeva, Gabriela, Capoccia, Benjamin J, Puro, Robyn J, Donio, Mike J, Hiebsch, Ronald R, Kashyap, Arun K, Pereira, Daniel S
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma
Capoccia, Benjamin J., Donio, Michael J., Richards, John O., Hiebsch, Ronald R., Puro, Robyn J., Kashyap, Arun K., Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Pre-Clinical Combination of AO-176, a Highly Differentiated Clinical Stage CD47 Antibody, with Either Azacitidine or Venetoclax Significantly Enhances DAMP Induction and Phagocytosis of Acute Myeloid Leukemia
Donio, Mike J, Wilson, W. Casey, Darwech, Isra, Andrejeva, Gabriela, Capoccia, Benjamin J, Puro, Robyn J, Kashyap, Arun K, Pereira, Daniel S
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics
Wilson, William Casey, Richards, John, Puro, Robyn J, Andrejeva, Gabriela, Capoccia, Ben J, Donio, Mike J, Hiebsch, Ronald R, Chakraborty, Prabir, Sung, Victoria, Pereira, Daniel S
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Abstract B100: AO-176, a highly differentiated humanized anti-CD47 antibody, exhibits single-agent and combination antitumor efficacy with chemotherapy and targeted antibodies
Wilson, Casey, Bouchlaka, Myriam, Puro, Robyn, Capoccia, Ben, Hiebsch, Ronald, Chakraborty, Prabir, Donio, Michael, Sung, Vicki, Pereira, Daniel
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Highly Differentiated Anti-CD47 Antibody, AO-176, Potently Inhibits Hematologic Malignancies Alone and in Combination
Richards, John, Bouchlaka, Myriam N, Puro, Robyn J, Capoccia, Ben J, Hiebsch, Ronald R, Donio, Michael J, Wilson, W. Casey, Chakraborty, Prabir, Sung, Victoria, Pereira, Daniel S
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Abstract 1765: A humanized anti-CD47 monoclonal antibody that directly kills human tumor cells and has additional unique functional characteristics
Puro, Robyn, Liu, Katherine, Capoccia, Benjamin, Donio, Michael, Hiebsch, Ronald, Bouchlaka, Myriam, Carter, Alun, Manning, Pamela, Crowley, Kathleen, Karr, Robert
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 548: Evaluation of novel SIRP antibodies as potential cancer therapeutics
Hiebsch, Ronald R., Bouchlaka, Myriam N., Capoccia, Benjamin J., Donio, Michael J., Chakraborty, Prabir, Wilson, W. Casey, Puro, Robyn J., Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 540: AO-176, a normal cell sparing humanized anti-CD47 antibody
Chakraborty, Prabir, Bouchlaka, Myriam N., Capoccia, Benjamin J., Hiebsch, Ronald R., Donio, Michael J., Puro, Robyn J., Sung, Vicki, Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies
Wilson, W. Casey, Bouchlaka, Myriam N, Capoccia, Ben J, Hiebsch, Ronald R, Donio, Michael J, Puro, Robyn J, Carter, Alun J, Chakraborty, Prabir, Manning, Pamela T, Karr, Robert W, Sung, Vicki, Pereira, Daniel S
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article